163 related articles for article (PubMed ID: 28657165)
1. Serum N-glycome alterations in breast cancer during multimodal treatment and follow-up.
Saldova R; Haakensen VD; Rødland E; Walsh I; Stöckmann H; Engebraaten O; Børresen-Dale AL; Rudd PM
Mol Oncol; 2017 Oct; 11(10):1361-1379. PubMed ID: 28657165
[TBL] [Abstract][Full Text] [Related]
2. Serum N-Glycome Characterization in Patients with Resectable Periampullary Adenocarcinoma.
Hamfjord J; Saldova R; Stöckmann H; Sandhu V; Bowitz Lothe IM; Buanes T; Lingjærde OC; Labori KJ; Rudd PM; Kure EH
J Proteome Res; 2015 Dec; 14(12):5144-56. PubMed ID: 26515733
[TBL] [Abstract][Full Text] [Related]
3. Plasma N-glycome composition associates with chronic low back pain.
Trbojević-Akmačić I; Vučković F; Vilaj M; Skelin A; Karssen LC; Krištić J; Jurić J; Momčilović A; Šimunović J; Mangino M; De Gregori M; Marchesini M; Dagostino C; Štambuk J; Novokmet M; Rauck R; Aulchenko YS; Primorac D; Kapural L; Buyse K; Mesotten D; Williams FMK; van Zundert J; Allegri M; Lauc G
Biochim Biophys Acta Gen Subj; 2018 Oct; 1862(10):2124-2133. PubMed ID: 29981899
[TBL] [Abstract][Full Text] [Related]
4. Changes in total plasma and serum N-glycome composition and patient-controlled analgesia after major abdominal surgery.
Gudelj I; Baciarello M; Ugrina I; De Gregori M; Napolioni V; Ingelmo PM; Bugada D; De Gregori S; Đerek L; Pučić-Baković M; Novokmet M; Gornik O; Saccani Jotti G; Meschi T; Lauc G; Allegri M
Sci Rep; 2016 Aug; 6():31234. PubMed ID: 27501865
[TBL] [Abstract][Full Text] [Related]
5. Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I.
Callewaert N; Schollen E; Vanhecke A; Jaeken J; Matthijs G; Contreras R
Glycobiology; 2003 May; 13(5):367-75. PubMed ID: 12626389
[TBL] [Abstract][Full Text] [Related]
6. Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC.
Saldova R; Asadi Shehni A; Haakensen VD; Steinfeld I; Hilliard M; Kifer I; Helland A; Yakhini Z; Børresen-Dale AL; Rudd PM
J Proteome Res; 2014 May; 13(5):2314-27. PubMed ID: 24669823
[TBL] [Abstract][Full Text] [Related]
7. High-Throughput Analysis of the Plasma N-Glycome by UHPLC.
Adamczyk B; Stöckmann H; O'Flaherty R; Karlsson NG; Rudd PM
Methods Mol Biol; 2017; 1503():97-108. PubMed ID: 27743361
[TBL] [Abstract][Full Text] [Related]
8. Glycosylation status of serum in inflammatory arthritis in response to anti-TNF treatment.
Collins ES; Galligan MC; Saldova R; Adamczyk B; Abrahams JL; Campbell MP; Ng CT; Veale DJ; Murphy TB; Rudd PM; Fitzgerald O
Rheumatology (Oxford); 2013 Sep; 52(9):1572-82. PubMed ID: 23681398
[TBL] [Abstract][Full Text] [Related]
9. Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.
Haakensen VD; Steinfeld I; Saldova R; Shehni AA; Kifer I; Naume B; Rudd PM; Børresen-Dale AL; Yakhini Z
Mol Oncol; 2016 Jan; 10(1):59-72. PubMed ID: 26321095
[TBL] [Abstract][Full Text] [Related]
10. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
Abd Hamid UM; Royle L; Saldova R; Radcliffe CM; Harvey DJ; Storr SJ; Pardo M; Antrobus R; Chapman CJ; Zitzmann N; Robertson JF; Dwek RA; Rudd PM
Glycobiology; 2008 Dec; 18(12):1105-18. PubMed ID: 18818422
[TBL] [Abstract][Full Text] [Related]
11. Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation.
Bones J; Mittermayr S; O'Donoghue N; Guttman A; Rudd PM
Anal Chem; 2010 Dec; 82(24):10208-15. PubMed ID: 21073175
[TBL] [Abstract][Full Text] [Related]
12. A rapid mass spectrometric strategy for the characterization of N- and O-glycan chains in the diagnosis of defects in glycan biosynthesis.
Faid V; Chirat F; Seta N; Foulquier F; Morelle W
Proteomics; 2007 Jun; 7(11):1800-13. PubMed ID: 17520685
[TBL] [Abstract][Full Text] [Related]
13. Microwave-assisted deglycosylation for rapid and sensitive analysis of N-glycans via glycosylamine derivatization.
Wu Y; Wang C; Luo J; Liu Y; Zhang L; Xia Y; Feng X; Liu BF; Lin Y; Liu X
Anal Bioanal Chem; 2017 Jun; 409(16):4027-4036. PubMed ID: 28417175
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
Arnold JN; Saldova R; Hamid UM; Rudd PM
Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
[TBL] [Abstract][Full Text] [Related]
16. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
17. The ascites N-glycome of epithelial ovarian cancer patients.
Biskup K; Braicu EI; Sehouli J; Tauber R; Blanchard V
J Proteomics; 2017 Mar; 157():33-39. PubMed ID: 28188862
[TBL] [Abstract][Full Text] [Related]
18. [Role of locoregional radiation therapy in breast cancer patients with negative lymph nodes after preoperative chemotherapy and mastectomy. The Institut Curie-Hôpital René-Huguenin experience].
Le Scodan R; Bruant S; Selz J; Bollet MA; Daveau C; de la Lande B; Lerebours F; Labib A; Stevens D
Cancer Radiother; 2011 Dec; 15(8):675-82. PubMed ID: 21831686
[TBL] [Abstract][Full Text] [Related]
19. Association of medication with the human plasma N-glycome.
Saldova R; Huffman JE; Adamczyk B; Mužinić A; Kattla JJ; Pučić M; Novokmet M; Abrahams JL; Hayward C; Rudan I; Wild SH; Wright AF; Polašek O; Lauc G; Campbell H; Wilson JF; Rudd PM
J Proteome Res; 2012 Mar; 11(3):1821-31. PubMed ID: 22256781
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive N-glycome profiling of cultured human epithelial breast cells identifies unique secretome N-glycosylation signatures enabling tumorigenic subtype classification.
Lee LY; Thaysen-Andersen M; Baker MS; Packer NH; Hancock WS; Fanayan S
J Proteome Res; 2014 Nov; 13(11):4783-95. PubMed ID: 25210975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
